The effectiveness of national influenza vaccination policies for at-risk populations over 5 seasons in a Scottish general practice

Vaccine

Volumn 26, Issue 29-30, 2008, Pages 3772-3777

  Sivaprakasam, V ^a   Douglas, J ^b   Selvaraj, S ^c   MacIntyre, S ^b   Carman, W F ^a  

^a West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^b Tweeddale Medical Practice   (United Kingdom)

^c Centre for Rural Health   (United Kingdom)

Author keywords

Influenza; Seroresponders; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; GENERAL PRACTICE; HEALTH CARE POLICY; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VIRUS A; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FAMILY PRACTICE; HEALTH POLICY; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; SCOTLAND;

EID: 45049084869     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.04.030     Document Type: Article

References (27)

1. Centers for Disease Control. Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep, May 01. 1998;47(RR-6):1-26.
2. See www.dh.gov.uk/en/Publichealth/Flu/Flugeneralinformation/DH_072767.
3. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., and Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 178 (1998) 53-60
4. Paul Glezen W., Greenberg S.B., Atmar R.L., Piedra P.A., and Couch R.B. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 283 Jan (2000) 499-505
5. Stephenson I., and Zambon M. The epidemiology of Influenza. Occup Med 52 5 (2002) 241-247
6. Nichol K.L., Lind A., Margolis K.L., Murdoch M., McFadden R., Hauge M., et al. The effectiveness of vaccination against influenza in healthy working adults. N Engl J Med 333 (1995) 889-893
7. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., and Levandowski R. Efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 123 (1995) 518-527
8. Hoskins T.W., Davies J.R., Allchin A., Miller C.L., and Pollock T.M. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet 2 7821 (Jul 21) (1973) 116-120
9. Hoskins T.W., Davis J.R., Smith A.J., Allchin A., Miller C.L., and Poliock T.M. Influenza at Christ's Hospital: march 1974. Lancet 1 7951 (Jan 17) (1976) 105-108
10. Hoskins T.W., Davis J.R., Smith A.J., Miller C.L., and Allchin A. Assessment of inactivated influenza A vaccine after three outbreaks of influenza at Christ's Hospital. Lancet 1 81036 (Jan 6) (1979) 33-35
11. Nicholson K.G. Annual vaccination: conclusions and recommendations. In: Hannoun C., Kendal A.P., Klenk H.D., and Ruben F.L. (Eds). Options for the control of influenza II, proceedings of the international conference on options for the control of influenza, vol. 27. September-2 to October 1992, Amsterdam (1993) 451-455
12. Keitel W.A., Cate T.R., and Couch R.B. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 127 2 (1988) 353-364
13. Gross P.A., Denning C.R., Gaerlan P.F., Bonelli J., Bernius M., Dran S., et al. Annual influenza vaccination: immune response in patients over 10 years. Vaccine 14 Sep (1996) 1280-1284
14. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 7574 Oct 28 (2006) 912-915
15. Govaert T.M., Sprenger M.J., Dinant G.J., Aretz K., Masurel N., and Knottnerus J.A. Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. Vaccine 12 13 (Oct) (1994) 1185-1189
16. Glathe H., Bigl S., and Grosche A. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. Vaccine 11 7 (1993) 702-705
17. Powers R.D., Hayden F.G., Samuelson J., and Gwaltney J.M. Immune response of adults to sequential influenza vaccination. J Med Viral 14 2 (1984) 169-175
18. Gross P.A., Quinnan Jr. G.V., Weksler M.E., Setia U., and Douglas Jr. R.G. Relation of chronic disease and immune response to influenza vaccine in the elderly. Vaccine 7 4 (Aug) (1989) 303-308
19. Allsup S., Gosney M., Haycox A., and Regan M. Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age. Health Technol Assess 7 24 (2003) 1-65
20. Postma M.J., Bos J.M., van Gennep M., Jager J.C., Baltussen R., and Sprenger M.J. Economic evaluation of influenza vaccination. Assessment for The Netherlands. Pharmacoeconomics 16 Suppl. 1 (1999) 33-40
21. Bridges C.B., Thompson W.W., Meltzer M.I., Reeve G.R., Talamonti W.J., Cox N.J., et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 284 13 (Oct 4) (2000) 1655-1663
22. Barker W.H., and Mullooly J.P. Influenza vaccination of elderly persons, Reduction in pnermonia and influenza hospitalizations and deaths. JAMA 244 22 (Dec 5) (1980) 2547-2549
23. Oshitani H., Saito R., Seki Nao., Tanabe N., Yamazaki O., Hayashi S., et al. Influenza vaccination levels and influenza-like illness in long-term-care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic. Inf Con Hosp Epidemiol 21 (2000) 728-730
24. Jefferson T., Rivetti D., Rivetti A., Rudin M., Di Pietrantonj C., and Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366 9492 (2005 Oct 1) 1165-1174
25. Gross P.A., Sperber S.J., Donabedian A., Dran S., Morchel G., Cataruozolo P., et al. Paradoxical response to a novel influenza virus vaccine strain: the effect of prior immunization. Vaccine 17 18 (May) (1999) 2284-2289
26. Keitel W.A., Cate T.R., Couch R.B., Huggins L.L., and Hess. K.R. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a 5 year period. Vaccine 15 (July) 10 (1997) 1114-1122
27. de Brujin I.A., Remarque E.J., Beyer W.E.Ph., Cessie S.l., Masurel N., and LigthartF Gerard J. Annually repeated influenza vaccination improves humoral responses to several influenza virus stains in healthy elderly. Vaccine 15 12-13 (1997) 1323-1329